Background Massive and submassive pulmonary embolism (PE) can be life-threatening.
Treatment options include anticoagulation, fibrinolysis, catheter-directed or open surgical …

Background Pulmonary embolism (PE) is a major cause of mortality with presentation
varying between few or no symptoms to sudden death. This makes timely and appropriate …

Management of intermediate and high risk acute pulmonary embolism (PE) is challenging.
The role of multidisciplinary teams for the care of these patients is emerging. Herein, we …

Pulmonary embolism (PE) treatment depends on disease severity and risk of complications.
Physician and institutional expertise may influence the use of reperfusion therapy (RT) such …

Treatment of patients with intermediate and high-risk pulmonary embolism (PE) is a
controversial area. Many therapeutic options exist, and deciding on appropriate treatment …

Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States.
Although new therapeutic tools and strategies have recently been developed for the …

Objectives The development of pulmonary embolism response teams (PERT s) has been
widely adopted nationally with the goal of providing multidisciplinary care to patients with …

Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary,
multispecialty team of experts in the care of highly complex symptomatic acute pulmonary …

Background Pulmonary embolism response teams (PERTs) have become increasingly
popular at institutions around the country, although the evidence to support their efficacy is …

1414 Correspondence[150# 6 CHEST DECEMBER 2016] follows: pulmonary/critical care
(84%), interventional cardiology (79%), and emergency medicine (63%)(Fig 1). All programs …